Medicare billing address
CMS Medicare provider billing file
700 W 800 N Ste 444Orem, UT 84057
CMS public data · NPI 1720475122
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Sean M Lawless, M.D.
Specialty
Credential
M.D.
NPI
1720475122
Primary source state
UT
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Sean M Lawless, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
700 W 800 N Ste 444CMS Doctors & Clinicians file
1055 N 500CMS Doctors & Clinicians file
1055 N 500 WCMS Doctors & Clinicians file
700 W 800In the 2024 CMS provider billing file, this NPI had 1,083 Medicare beneficiaries and 5,125 total services. The average beneficiary age was 76, and the average HCC risk score was 1.5.
Total Medicare allowed amount
$557,927.97
Total Medicare payment amount
$433,299.87
Medicare beneficiaries
1,083
Total services
5,125
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
75%
CMS beneficiary-panel share
Hyperlipidemia
73%
CMS beneficiary-panel share
Ischemic heart disease
47%
CMS beneficiary-panel share
Heart failure
36%
CMS beneficiary-panel share
Atrial fibrillation
35%
CMS beneficiary-panel share
Diabetes
35%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 607 | $15.64 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 521 | $121.56 |
| Injection, regadenoson, 0.1 mg | 428 | $6.02 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 339 | $64.47 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 269 | $182.32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 262 | $13.43 |
| Insertion of needle into vein for collection of blood sample | 198 | $8.57 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 191 | $506.55 |
| Blood test, basic group of blood chemicals (calcium, total) | 137 | $8.18 |
| Blood test, lipids (cholesterol and triglycerides) | 131 | $12.99 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1720475122. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Metoprolol Succinate | Metoprolol Succinate | 528 | 1,326.5 | $8,062.50 |
| 2 | Rosuvastatin Calcium | Rosuvastatin Calcium | 426 | 1,182.1 | $6,810.96 |
| 3 | Eliquis | Apixaban | 350 | 690.6 | $392,393.90 |
| 4 | Atorvastatin Calcium | Atorvastatin Calcium | 323 | 924 | $4,239.65 |
| 5 | Farxiga | Dapagliflozin Propanediol | 321 | 527.3 | $294,386.63 |
| 6 | Clopidogrel | Clopidogrel Bisulfate | 254 | 699.7 | $3,649.39 |
| 7 | Amlodipine Besylate | Amlodipine Besylate | 243 | 653.4 | $1,799.81 |
| 8 | Spironolactone | Spironolactone | 183 | 490.7 | $1,721.49 |
| 9 | Carvedilol | Carvedilol | 165 | 466.7 | $1,599.08 |
| 10 | Furosemide | Furosemide | 155 | 424 | $907.77 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2015
Group/practice field
Revere Health Pc
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.